363 related articles for article (PubMed ID: 32091339)
21. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
Alhowail AH; Aldubayan M
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-Induced Cognitive Impairment.
Kinsley K; Pritchett W
Clin J Oncol Nurs; 2023 Mar; 27(2):205-208. PubMed ID: 37677835
[TBL] [Abstract][Full Text] [Related]
23. The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain".
Gaman AM; Uzoni A; Popa-Wagner A; Andrei A; Petcu EB
Aging Dis; 2016 May; 7(3):307-17. PubMed ID: 27330845
[TBL] [Abstract][Full Text] [Related]
24. [An overview of the research of cancer-related cognitive impairment].
Ferencz V; S Nagy Z; Tóth M
Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
[TBL] [Abstract][Full Text] [Related]
25. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
Sahu K; Singh S; Devi B; Singh C; Singh A
Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
[TBL] [Abstract][Full Text] [Related]
26. Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
Tong Y; Wang K; Sheng S; Cui J
Biosci Biotechnol Biochem; 2020 Jun; 84(6):1201-1210. PubMed ID: 31992173
[TBL] [Abstract][Full Text] [Related]
27. [Chemobrain - cognitive disorders after chemotherapy].
Kupryjaniuk A; Sobstyl M
Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
[TBL] [Abstract][Full Text] [Related]
28. The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment.
Subramaniam CB; Bowen JM; Gladman MA; Lustberg MB; Mayo SJ; Wardill HR
Neurosci Biobehav Rev; 2020 Sep; 116():470-479. PubMed ID: 32681936
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
30. Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial.
Zhang ZJ; Man SC; Yam LL; Yiu CY; Leung RC; Qin ZS; Chan KS; Lee VHF; Kwong A; Yeung WF; So WKW; Ho LM; Dong YY
Brain Behav Immun; 2020 Aug; 88():88-96. PubMed ID: 32305573
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced cognitive impairment from the forensic medicine perspective: A review of the updated literature.
Turrina S; Gibelli F; De Leo D
J Forensic Leg Med; 2020 Nov; 76():102070. PubMed ID: 33099125
[TBL] [Abstract][Full Text] [Related]
32. Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice.
Sung PS; Chen PW; Yen CJ; Shen MR; Chen CH; Tsai KJ; Lin CK
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439331
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions.
Sekeres MJ; Bradley-Garcia M; Martinez-Canabal A; Winocur G
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884513
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma.
John J; Kinra M; Ranadive N; Keni R; Nayak PG; Jagdale RN; Ahmed SM; Raghavendra KV; Mudgal J; Nandakumar K
Sci Rep; 2022 Feb; 12(1):3072. PubMed ID: 35197512
[TBL] [Abstract][Full Text] [Related]
35. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
Guran E; Hu J; Wefel JS; Chung C; Cata JP
Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options.
Di Iulio F; Cravello L; Shofany J; Paolucci S; Caltagirone C; Morone G
Neurol Sci; 2019 Sep; 40(9):1759-1774. PubMed ID: 31049790
[TBL] [Abstract][Full Text] [Related]
37. Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration.
Cardoso CV; de Barros MP; Bachi ALL; Bernardi MM; Kirsten TB; de Fátima Monteiro Martins M; Rocha PRD; da Silva Rodrigues P; Bondan EF
Behav Brain Res; 2020 Jan; 378():112233. PubMed ID: 31521736
[TBL] [Abstract][Full Text] [Related]
38. The effect of systemic chemotherapy on neurogenesis, plasticity and memory.
Wigmore P
Curr Top Behav Neurosci; 2013; 15():211-40. PubMed ID: 23239468
[TBL] [Abstract][Full Text] [Related]
39. Chemobrain: A review on mechanistic insight, targets and treatments.
Rao V; Bhushan R; Kumari P; Cheruku SP; Ravichandiran V; Kumar N
Adv Cancer Res; 2022; 155():29-76. PubMed ID: 35779876
[TBL] [Abstract][Full Text] [Related]
40. Animal models of chemotherapy-induced cognitive decline in preclinical drug development.
John J; Kinra M; Mudgal J; Viswanatha GL; Nandakumar K
Psychopharmacology (Berl); 2021 Nov; 238(11):3025-3053. PubMed ID: 34643772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
